Uterotonics in pregnant patients with cardiac disease: a focused review
Study context
- Population
- Pregnant women with cardiac disease receiving uterotonics to prevent or treat postpartum haemorrhage
- Outcome
- Pharmacology, haemodynamic effects and clinical considerations of uterotonics
Methodological detailsnarrative review of studies, case series and consensus recommendations
- Narrative review of studies, case series and consensus recommendations
Recommendations
As reported in the abstract
- Uterotonics can alter systemic vascular resistance, myocardial contractility, pulmonary artery pressure and heart rate, with implications varying by cardiac pathology
- Oxytocin and carbetocin discussed in detail; alternatives carboprost, ergometrine, misoprostol; adjuncts calcium and TXA
Original publication
Uterotonics in pregnant patients with cardiac disease: a focused review. Int J Obstet Anesth. Published 6 March 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →